REBECCA JURGENS: Open Payments
NPI 1396901518 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 22 payments from 4 companies in 2025. Trend: 2023 $110 · 2024 $428 · 2025 $348
Food & beverage: $264Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $261 |
| Amgen Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $22 |
Products named: TREMFYA, UPLIZNA, XIFAXAN, REZDIFFRA.
Industry payments across NE — which companies pay providers there.
